Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMycelx Di Regulatory News (MYX)

Share Price Information for Mycelx Di (MYX)

Share Price is delayed by 15 minutes
Get Live Data
57.50    -8.00 (-12.21%)
Bid:
57.00
Ask:
58.00
Spread: 1.00 (1.754%)
Market Cap: £14.01m
MYX Live PriceLast checked at - London Stock Exchange

Intraday Mycelx Di Share Chart

Directorate change

Today 07:00

RNS Number : 2332K
MyCelx Technologies Corporation
30 June 2026
 

30 June 2026

 

MYCELX TECHNOLOGIES CORPORATION

("MYCELX" or the "Company")

 

Directorate Change

 

MYCELX Technologies Corporation (AIM: MYX), a leading provider of proprietary water treatment technology to the Oil and Gas and other industries worldwide, today announces that Gareth Kaminski-Cook has informed the Board of his decision to step down as Chair and Director of the Company with effect from 31 July 2026.

 

Mr. Kaminski- Cook is looking to reduce work commitments and believes that the timing is right, given the Company's growing momentum in the execution of its growth strategy and the significant progress made in strengthening the Group's operational and commercial position.

 

The Board confirms that Tom Lamb, currently Senior Independent Director of the Company and previously Chair of MYCELX during the period 7 July 2021 to 23 September 2025, will assume the role of Interim Chair from 1 August 2026. Mr Lamb's extensive knowledge of the Company, its markets and stakeholders will provide continuity and stability whilst the Board undertakes a process to find and appoint a permanent Chair.

 

Gareth Kaminski-Cook, outgoing Chair, commented:

 

"It has been a privilege to serve as Chair of MYCELX. Together, the Board and management team have worked hard to position the Company for sustainable growth. With strong momentum behind the execution of our strategy and a solid platform for future success, the Company is very well positioned for profitable growth. I would like to thank my fellow Directors, management, employees, customers and shareholders for their support and commitment during my tenure."

 

Tom Lamb, Interim Chair, commented:

 

"On behalf of the Board, I would like to thank Gareth for his leadership and commitment to MYCELX. His guidance and consistent support of our strategy throughout a period of strong execution and meaningful progress have set the Company on solid footing for the growth ahead. I look forward to supporting the Board and management team as Interim Chair whilst we conduct a thorough process to appoint a permanent Chair."

 

The Board would like to express its sincere gratitude to Mr. Kaminski-Cook for his service, leadership and contribution to the Company and wishes him every success for the future.

 

For further information, please contact: 

 

MYCELX Technologies Corporation

Connie Mixon, CEO

Kim Slayton, CFO

 

 

 

Tel: +1 888 306 6843

Cavendish Capital Markets Limited (Nominated Adviser and Sole Broker)

Giles Balleny / Elysia Bough (Corporate Finance

Harriet Ward (Corporate Broking)

Jasper Berry / Michael Johnson (Sales)

 

Tel: +44 20 7220 0500

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABUGDLUGDDGLC
Date   Source Headline
30th Jun 20267:00 amRNSDirectorate change
16th Jun 202611:29 amRNSAnnual Financial Report
3rd Jun 20267:00 amRNSAppointment of Non-Executive Director
12th May 20267:00 amRNSNew Gulf of Mexico Lease Award with Super Major
7th May 20267:00 amRNSFinal Results for the Year Ending 31 December 2025
16th Feb 202610:46 amRNSDirector Dealing
20th Jan 20267:00 amRNSTrading Update
22nd Dec 202511:27 amRNSHolding(s) in Company
7th Nov 20252:51 pmRNSHolding(s) in Company
3rd Nov 20257:00 amRNSTrading Update & $3.9m Project Award
1st Oct 20257:00 amRNSHolding(s) in Company
23rd Sep 20255:00 pmRNSResult of Annual Meeting
23rd Sep 20257:00 amRNSAppointment of New Chairman and Succession
17th Sep 20257:00 amRNSHalf Year Results Statement
11th Sep 20257:00 amRNSClosure of Restricted Stock Line
22nd Aug 20257:00 amRNSMailing of Notice of 2025 Annual Meeting
20th Aug 20257:00 amRNSOpening of $500,000 Line of Credit
17th Jul 20257:00 amRNSTrading Update
10th Jun 20257:00 amRNSMailing of 2024 Annual Report
21st May 20253:25 pmRNSDirector Dealing
19th May 202511:33 amRNSHolding(s) in Company
15th May 202511:21 amRNSHolding(s) in Company
12th May 20257:00 amRNSFinal Results for the Year Ending 31 December 2024
6th May 20257:00 amRNSPFAS Contract Award
1st May 20257:00 amRNS-REPA Announces Actions to Combat PFAS Contamination
10th Apr 20257:00 amRNSGrant of Share Options
7th Apr 20257:00 amRNSOperational and Trading Update
30th Jan 20257:00 amRNSChange of Adviser
6th Jan 20257:00 amRNSYear-end Update
29th Oct 20247:00 amRNSProject Award
24th Sep 20247:00 amRNSHalf Year Results Statement
23rd Sep 20247:00 amRNSTrading Update
6th Sep 202411:54 amRNSHolding(s) in Company
5th Sep 20245:17 pmRNSHolding(s) in Company
30th Aug 20247:00 amRNSBroker Option
23rd Aug 202411:05 amRNSDirector Dealings & Total Voting Rights
23rd Aug 20247:00 amRNSProposed Placing and Subscription
19th Jul 202410:36 amRNSPFAS Update
9th Jul 20242:23 pmRNSResult of AGM
9th Jul 20241:39 pmRNSHolding(s) in Company
4th Jun 20247:00 amRNS2023 Annual Report & Notice of 2024 Annual Meeting
21st May 20247:00 amRNSDirector Dealing
16th May 20247:00 amRNSFinal Results for the Year Ending 31 December 2023
24th Apr 20247:00 amRNSBusiness Update
11th Apr 20247:00 amRNSEPA Publishes National Drinking Water Standards
26th Mar 20243:30 pmRNSDirector Dealing
26th Mar 20247:00 amRNSDirector Dealing
22nd Mar 20247:00 amRNSDirector Dealing
21st Mar 20247:00 amRNSDirector Dealing
18th Mar 20247:00 amRNSGrant of Share Options to Chief Financial Officer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.